Prospective, Randomized Controlled Trial on Perioperative Pregabalin to Reduce Late-onset CRPS After TKA

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
CRPS
Interventions
DRUG

pregabalin

PO pregabalin 300 mg 2 hours prior to surgery, and 150 mg twice a day for 10 postoperative days. Pregabalin will be tapered to 75 mg twice daily between days 11 to 12 and then to 50 mg twice daily between days 13 to 14 post operatively and then stopped.

DRUG

Placebo

Placebo for Given 2 hours prior to surgery, and twice a day for 14 postoperative days.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Rush University Medical Center

OTHER